

HY-P99159 · 1 mg
MedChemExpress · Cat: HY-P99159
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ivuxolimab.html
Description
Ivuxolimab is a fully human IgG2 agonist targeting OX40 CD134 , which selectively binds to the OX40 receptor on the surface of activated CD4+ and CD8+ T cells without inducing antibody-dependent cytotoxicity. Ivuxolimab can promote T cell proliferation, survival and cytokine such as IFN-?, IL-2 secretion, inhibit regulatory T cell function, and enhance anti-tumor immune response. Ivuxolimab can be used in the study of melanoma, hepatocellular carcinoma, head and neck squamous cell carcinoma, etc.







